Endocannabinoid receptor CB2 in nonalcoholic fatty liver disease

Background and Aim: Fatty infiltration and fibrosis are major issues in chronic liver disease. Recent reports suggest a role for the endocannabinoid system in these processes. Aim: To characterize localization and expression of CB2 in normal liver and nonalcoholic fatty liver. Methods: We studied 64...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Liver international 2007-03, Vol.27 (2), p.215-219
Hauptverfasser:	Mendez-Sanchez, N., Zamora-Valdes, D., Pichardo-Bahena, R., Barredo-Prieto, B., Ponciano-Rodriguez, G., Bermejo-Martínez, L., Chavez-Tapia, N. C., Baptista-González, H. A., Uribe, M.
Format:	Artikel
Sprache:	eng
Schlagworte:	endocannabinoids Fatty Liver - metabolism Fatty Liver - pathology Hepatitis - metabolism Hepatitis - pathology Humans Immunohistochemistry liver Liver - metabolism Liver - pathology nonalcoholic fatty liver disease Prospective Studies Receptor, Cannabinoid, CB2 - genetics Receptor, Cannabinoid, CB2 - metabolism Reverse Transcriptase Polymerase Chain Reaction RNA, Messenger - metabolism Tissue Distribution
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!